Echistatin, a snake-venom RGD-containing protein, was previously shown to disrupt cell-matrix adhesion by a mechanism that involves the reduction of pp125 FAK tyrosine phosphorylation levels. The aim of this study was to establish the sequence of events downstream pp125 FAK dephosphorylation that could be responsible for echistatin-induced disassembly of actin cytoskeleton and focal adhesions in fibronectin-adherent B16-BL6 melanoma cells. The results obtained show that echistatin induces a decrease of both autophosphorylation and kinase activity of pp125 FAK . One hour of cell exposure to echistatin caused a 39% decrease of pp125 FAK Tyr397 phosphorylation and a 31% reduction of pp125 FAK autophosphorylation activity as measured by immunecomplex kinase assay. Furthermore, 1 h of cell treatment by echistatin produced a 63% decrease of paxillin phosphorylation, as well as a reduction in the amount of paxillin bound to pp125
Echistatin belongs to a family of low molecular mass, Arg-GlyAsp (RGD)-containing proteins isolated from the venom of various snakes [1±4] . These proteins are termed disintegrins for their ability to bind with high affinity integrin receptors on platelets and cell surfaces. Inhibition of platelet aggregation and of cell adhesion has been the first biological activity reported for disintegrins [5] . The ability of some disintegrins to inhibit experimental metastasis in vivo has also been proved [6±10] . The exact molecular mechanism by which disintegrins act is still unclear; however, the finding that disintegrins affect integrin-dependent cell signaling provided some new insights into it [11±13] .
We previously demonstrated that echistatin, a small-size disintegrin, inhibits B16-BL6 murine melanoma cell adhesion to extracellular matrix (ECM) components and detaches fibronectin-adherent melanoma cells from the substratum [13, 14] . Echistatin-induced disruption of cell±matrix interactions in fibronectin-adherent B16-BL6 cells appears to involve an early reduction of pp125 FAK phosphorylation that correlates with the disassembly of actin cytoskeleton and of focal adhesions. However, the functional relationship between these events has not been established.
The 68-kDa protein paxillin, a component of focal adhesions, is a substrate of pp125 FAK or of a kinase activated by pp125 FAK [15] . The integrin-dependent phosphorylation of pp125 FAK and paxillin has been observed in many cell types [16] . Elevated content of tyrosine phosphorylated pp125 FAK and paxillin has been found in cells transformed by Rous sarcoma virus [17] and in cells during embryogenesis [18] . Different stimuli, including lysophosphatidic acid [19] , platelet-derived growth factor [20] and the neuropeptides bombesin, endothelin and vasopressin [21] are able to induce the phosphorylation of both pp125 FAK and paxillin in cultured cells. pp125 FAK directly associates with paxillin and a region of pp125 FAK that overlaps the focal adhesion-targeting (FAT) sequence [22±25] mediates this association. However, the targeting of pp125 FAK to the focal adhesions and its binding to paxillin seem to involve different structural interactions, as a mutation of the distal C-terminal sequence of pp125 FAK inhibits binding without blocking its translocation to focal adhesions [23] . A correct subcellular localization and autophosphorylation of pp125 FAK are required for the tyrosine phosphorylation of paxillin in vivo [15] ; phosphorylation of paxillin creates binding sites for SH-2 domain-containing signaling molecules such as Crk and Csk [25] . Whether pp125 FAKmediated tyrosine phosphorylation of paxillin is important for its recruitment or function at focal adhesions is not yet completely established. Cultured cells from pp125 FAK -deficient mouse embryos showed no differences compared to wild-type cells in the levels of tyrosine phosphorylated tensin, paxillin, vinculin and talin, or in their localization to focal adhesions [26] . Further, mutations of Tyr118, the major site of tyrosine phosphorylation in the paxillin molecule, didn't affect its localization to focal adhesions [27] .
In order to better understand the sequence of events underlying echistatin-induced disruption of cell±matrix interactions in fibronectin-adherent B16-BL6 melanoma cells we evaluated whether echistatin affects: (a) phosphorylation of pp125 FAK Tyr397 residue; (b) pp125 FAK autophosphorylation activity; (c) pp125
FAK -pp60 src binding; (d) paxillin tyrosine phosphorylation; (e) paxillin±pp125 FAK association; (f) the localization of the two proteins in focal adhesions.
M A T E R I A L S A N D M E T H O D S

Antibodies
Monoclonal anti-phosphotyrosine (PT66) IgG, horseradish peroxidase conjugated goat anti-(mouse IgG) Ig, horseradish peroxidase conjugated goat anti-(rabbit IgG) Ig, tetramethylrhodamine isothiocyanate (TRITC) conjugated goat anti-(rabbit IgG) Ig and fluorescein isothiocyanate (FITC) conjugated rabbit anti-(mouse IgG) Ig were purchased from Sigma (St Louis, MO, USA); rabbit polyclonal anti-(chicken focal adhesion kinase) Ig (BC3) and polyclonal rabbit anti-(human focal adhesion kinase) Ig from Upstate Biotechnology (Lake Placid, NY, USA); monoclonal mouse anti-paxillin IgG from Transduction Laboratories (Lexington, KY, USA); monoclonal mouse anti-pp60 src IgG (clone 327) from Calbiochem (Cambridge, MA, USA). Anti-pp125
FAK serum was also a kind gift of J. T. Parsons (University of Virginia, Charlottesville, VA, USA). Anti-(phosphotyrosine 397) Ig (number 625857) was obtained by the described procedure [28] . This antibody reacted with the autophosphorylated form of pp125 FAK but not with other phosphoproteins.
Chemicals
Aprotinin, bovine serum albumin (BSA), echistatin, human plasma fibronectin, leupeptin, nonessential amino acids, orthovanadate, pepstatin and sodium pyruvate were purchased from Sigma; Eagle's minimal essential medium (MEM), glutamine and vitamine solution were from ICN Biomedicals Inc. (Aurora, OH, USA); fetal bovine serum from Hyclone Laboratories Inc. (Logan, UT, USA); protein A±agarose or protein G±agarose from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA). The adhesive protein fibronectin appeared greater than 95% homogeneous by SDS/PAGE analysis and Coomassie blue staining.
Cell culture and adhesion B16-BL6 mouse melanoma cells were grown in MEM supplemented with 10% fetal bovine serum, 1% nonessential amino acid solution, 2% vitamin solution, 1% sodium pyruvate solution and 1% glutamine. Cells were harvested for propagation or cell attachment studies by treatment with 0.25% trypsin/ 0.02% EDTA in NaCl/P i , pH 7.2, and in 5 mm EDTA in NaCl/ P i , respectively. Cells were then washed with MEM and resuspended in complete MEM for propagation or in serum free MEM for adhesion studies. For gel and blot analysis cells were plated at 1 Â 10 6 cells per 6-cm culture dish. Coverslips or tissue culture dishes were coated overnight at 4 8C by incubation with 0.1 mL human plasma fibronectin (10 mg´mL
21
) diluted in NaCl/P i with 1 mm CaCl 2 and 1 mm MgCl 2 . After coating, coverslips or dishes were treated with 1% BSA in NaCl/P i for 30 min at 37 8C to block free binding sites on the plastic. Before plating cells, coverslips or dishes were rinsed twice in NaCl/P i .
Fluorescence microscopy
Cells were plated onto fibronectin-coated coverslips and incubated for 3 h in serum-free medium at 37 8C. Non-adherent cells were removed by washing with serum free medium and fibronectin-adherent cells were exposed to 100 mg´mL 21 echistatin for 30 min. At the indicated time, the cells were washed, fixed in 3% paraformaldehyde, 60 mm sucrose in NaCl/P i for 20 min at room temperature, permeabilized with 0.2% Triton X-100 in NaCl/P i for 2 min and blocked by the addition of 1% BSA in NaCl/P i for 30 min. Cells were incubated for 1 h at room temperature with primary antibodies, washed three times in NaCl/P i , exposed to a 1 : 20 dilution of rhodamine-conjugated goat anti-(rabbit IgG) Ig for 1 h, washed three times in NaCl/P i and exposed to a 1 : 20 dilution of fluorescein-conjugated rabbit anti-(mouse IgG) Ig for 1 h. After final washes with NaCl/P i , the coverslips were mounted on a microscope slide using a 50% solution of glycerol in NaCl/P i and the stained cells were examined with a Zeiss Axiophot microscope.
Immunoprecipitation, immunoblotting and immune-complex kinase assay Cells were kept in suspension for 30 min or plated on substratecoated dishes and allowed to adhere at 37 8C for different time intervals. In the inhibition studies, cells were allowed to adhere for 3 h, washed with serum-free medium and exposed to 100 mg´mL 21 of echistatin for the indicated time. At the end of the incubation time, cells were lysed in ice-cold Tris/NaCl/P i containing 1% NP-40, 150 mm NaCl, 50 mm Tris HCl (pH 8), 5 mm EDTA, 10 mm NaF, 10 mm Na 4 P 2 O 7 , 0.4 mm Na 3 VO 4 , 10 mg´mL 21 leupeptin, 4 mm pepstatin and 0.1 U trypsin per mL aprotinin. The lysates were clarified by centrifugation at 12 000 g for 10 min at 4 8C. The amount of proteins in the samples was determined by Bio-Rad DC protein assay (BioRad Laboratories, Hercules, CA, USA). Lysates containing equal amounts of proteins were incubated with swelled protein A±agarose or protein G±agarose for 2 h at 4 8C. After centrifugation at 12 000 g for 10 min, supernatant fractions were incubated with anti-pp125 FAK serum (BC3), anti-paxillin Ig or anti-pp60 src Ig (1 mg per 200 mg protein) for 6 h at 4 8C. Protein A±agarose or G±agarose was then added to the samples and incubated overnight at 4 8C. Beads were sedimented by brief centrifugation after immunoprecipitation and washed extensively with lysis buffer. Proteins were resuspended in SDS sample buffer, boiled for 5 min in Laemmli buffer and run on 10% SDS/polyacrylamide gels. Following electrophoresis, the samples were transferred to nitrocellulose using a Mini Trans-Blot apparatus (Bio-Rad) according to manufacturer's instructions, blocked for 1 h at 42 8C in Tris/NaCl/P i containing 5% BSA, and washed with Tris/NaCl/P i /Tween (150 mm NaCl, 20 mm Tris HCl, pH 7.4, 0.3% Tween 20). To probe for phosphotyrosine-containing proteins the filters were incubated overnight with a 1 : 10 000 dilution of antibody PT66 diluted in Tris/NaCl/P i , 1% BSA. Control blots using anti-pp125 FAK or anti-paxillin Ig instead of anti-phosphotyrosine Ig PT66 were always run to confirm equal loading of pp125 FAK or of paxillin in the lysates. The blots were washed three times with Tris/ NaCl/P i /Tween, incubated 2 h with peroxidase conjugated anti-(mouse IgG) Ig diluted 1 : 3000 in Tris/NaCl/P i , 1% BSA, and washed three times with Tris/NaCl/P i /Tween. The proteins were visualized by an ECL chemiluminescence kit (Amersham Corp., Little Chalfont, UK). Quantitation of tyrosine phosphorylated proteins was performed by densitometry using a Discover Pharmacia scanner equipped with a sun spark classic densitometric workstation.
For kinase assay pp125 FAK was immunoprecipitated from 500 mg of lysates as described above. The immunoprecipitates were washed four times in lysis buffer and twice in kinase buffer (50 mm Tris/HCl, pH 7.4, 10 mm MgCl 2 , 10 mm MnCl 2 , 1 mm dithiothreitol). After the final wash, the pellets were resuspended in 20 mL of kinase buffer and the reaction initiated by the addition of 15 mCi [g- 
R E S U L T S
Tyrosine phosphorylation of both pp125 FAK and paxillin coordinately occurs when cells are plated on fibronectin coated dishes [16] . Adhesion of B16-BL6 melanoma cells to immobilized fibronectin led to a time-dependent increase of tyrosine phosphorylation of pp125 FAK and paxillin. The maximum level of phosphorylation of pp125 FAK was observed after 30 min of cell adhesion to fibronectin. Paxillin peak of phosphorylation appeared to occur slightly later than that of pp125 FAK . High phosphorylated levels of both proteins persisted up to 3 h (data not shown).
We previously observed that echistatin reduces pp125 FAK tyrosine phosphorylation in fibronectin-adherent B16-BL6 cells [13] . At least six tyrosines of pp125 FAK can be phosphorylated subsequent to integrin engagement: two sites within pp125 FAK N-terminal domain, two sites within kinase domain activation loop, and two sites within the C-terminal domain are phosphorylated in vivo [29] . Here, we evaluated whether the reduction of pp125 FAK phosphorylation induced by echistatin occurs at Tyr397 that is the site of pp125 FAK autophosphorylation activity both in vitro and in vivo [30] . Lysates containing equal amounts of proteins from fibronectin-adherent B16-BL6 cells exposed for different time intervals to 100 mg´mL 21 of echistatin were subjected to SDS/PAGE electrophoresis and to Western blotting by using a specific antibody (no. 625857) which recognizes Tyr397 phosphorylated pp125
FAK [28] . Fifteen min of echistatin treatment promoted a 69% decrease of Tyr397 phosphorylated pp125 FAK levels as compared to control (untreated) cells (Fig. 1A) . Prolonged cell exposure to echistatin for 30 and 60 min resulted in a lower decrease of Tyr397 phosphorylation with respect to control cells than that observed at 15 min of echistatin treatment. However, when pp125 FAK immune-complexes from the same lysates were also blotted against antiphosphotyrosine Ig PT66, the expected time-dependent decrease of pp125 FAK phosphorylation induced by echistatin was observed (data not shown). This might indicate that echistatin-induced inhibition of pp125 FAK Tyr397 phosphorylation persists for a shorter time with respect to other pp125 FAK tyrosines. q
As the phosphorylation of Tyr397 is required for pp125 FAK autophosphorylation activity, we also measured the effect of echistatin on this activity by immune-complex kinase assay and autoradiography ( Fig. 2A) (Fig. 2B) . Interestingly, 1 h of cell exposure to echistatin caused a comparable extent of reduction of both pp125 FAK Tyr397 phosphorylation (39%) (Fig. 1A,  lane 3 ) and pp125
FAK autophosphorylation activity (31%) (Fig. 2A, lane 3) .
In order to assess the effect of echistatin-induced reduction of pp125 FAK phosphorylation on paxillin tyrosine phosphorylation, B16-BL6 cells were allowed to adhere to fibronectin for 3 h and then exposed to the disintegrin for different time intervals. Immunoprecipitation of cell lysates with anti-paxillin Ig followed by immunoblotting with anti-phosphotyrosine Ig showed that echistatin causes a decrease of paxillin phosphorylation as a function of the time of cell exposure to the disintegrin (Fig. 3A) . Within 15 min of cell exposure to echistatin, paxillin phosphorylation decreased already by 42% as compared to control (untreated) cells; 1 h and 3 h of cell treatment by the disintegrin caused a 63% and 68% decrease of paxillin phosphorylation, respectively.
As src , as compared to control (untreated) cells (Fig. 4A) . We previously demonstrated that fibronectin-adherent B16-BL6 cells develop focal contacts where b 1 -containing integrins, possibly a 5 b 1 , are clustered as determined by immunofluorescence techniques [13] . We show now that pp125 FAK and paxillin colocalize in these structures (Fig. 5A,B) . However, immunofluorescence staining of cells with anti-pp125 FAK serum and anti-paxillin Ig suggests that only a fraction of these proteins is concentrated in focal contacts, a significant fluorescence signal being localized in the cytoplasm, in the perinuclear region (Fig. 5A,B) . Echistatin treatment of fibronectin-adherent cells induced a progressive albeit rapid detachment of cells from its substrata (Fig. 5C,D) . It is likely that adhesion plaques get disassembled upon echistatin interaction with cell membranes. Adhesion plaques are always positive to both anti-pp125 FAK serum and anti-paxillin Ig staining suggesting that the two proteins colocalize and that both coordinately respond to echistatin treatment.
We studied the association of pp125 FAK with paxillin to evaluate the effect of echistatin on it. pp125 FAK immune complexes prepared from lysates of B16-BL6 cells held in suspension or allowed to adhere to fibronectin for different time intervals were probed with anti-paxillin Ig in order to determine the presence of coprecipitating paxillin. The association of some paxillin with pp125 FAK was observed in cells held in suspension (Fig. 6A, lane 1, upper blot) ; however, an increase of the amount of paxillin coprecipitating with pp125
FAK was observed following cell adhesion to fibronectin (Fig. 6A, lanes  2±5, upper blot) . The amount of total paxillin was also determined by sequential rounds of immunoprecipitations with anti-paxillin Ig (data not shown). In this way we could calculate the amount of paxillin coprecipitating with pp125 FAK which resulted to be approximately 20% of the total paxillin present in the cell lysates, when cells adhered for 3 h to immobilized fibronectin. The addition of echistatin to fibronectin-adherent cells caused a time-dependent decrease of the amount of paxillin coprecipitating with pp125 FAK (Fig. 6B, upper blot) . Fifteen min and 1 h of cell exposure to the disintegrin caused, respectively, 60% and 69% decrease of coprecipitating paxillin as compared to control cells.
D I S C U S S I O N
We recently demonstrated that the interaction of echistatin with integrin receptors on B16-BL6 melanoma cells causes a reduction of pp125 FAK tyrosine phosphorylation, which is accompanied by the disassembly of actin cytoskeleton and of focal adhesions [13] . Here we show that echistatin molecular mechanism of action involves: (a) the reduction of pp125 FAK and paxillin become phosphorylated following B16-BL6 melanoma cell adhesion to immobilized fibronectin. However, paxillin phosphorylation occurrs slightly later than pp125 FAK phosphorylation. Thus paxillin might be a direct substrate for phosphorylation by pp125 FAK , or might serve as a substrate for a second protein kinase (PTK) that can be potentially activated by pp125 FAK , i.e. pp60 src or Csk [15, 31] . The phosphorylation of pp125 FAK most likely represents an autophosphorylation event that is required for the phosphorylation of downstream targets, including paxillin [32, 33] . A model of pp125 FAK activation proposed by Giancotti [34] suggests that the interaction of amino-terminal domain of pp125 FAK , which plays a negative autoregulatory role by folding back onto the catalytic domain, with the integrin b subunit tail results in a conformational change and oligomerization of pp125 FAK molecules. These become activated by a trans-autophosphorylation mechanism similar to that established for receptor tyrosine kinases. Echistatin is likely to directly interact with integrins [3, 35, 36] . It might promote a conformational change of integrin molecules that could affect the interaction of their b-cytoplasmic tails with the amino terminus domain of pp125 FAK causing the subsequent block of pp125 FAK activation. Activated pp125
FAK undergoes autophosphorylation at tyrosine residue 397 which creates a binding site for the SH2 domain of Src (and Fyn), possibly resulting in the formation of a bipartite kinase complex composed of pp125 FAK and Src (or Fyn) [32, 37] . The formation of this bipartite complex is an early and critical event in the assembly of focal adhesion complexes and in the activation of integrin signaling pathways. A likely in vivo substrate for the complex has been suggested to be paxillin [29] . We demonstrate here that echistatin treatment results in a decrease of pp125 FAK Tyr397 phosphorylation and of its autophosphorylation activity, as measured by immunecomplex kinase assay. We also demonstrate that a decrease of paxillin phosphorylation occurs. Even though paxillin is considered a target for pp125 FAK FAK exhibits only low levels of in vitro kinase activity [38] . Furthermore, Phe-397 pp125 FAK exhibits significant kinase activity in vitro even though does not associate with Src-family PTKs [29, 32] .
As paxillin is a good substrate for activated Src [39] , it is possible that the phosphorylation of paxillin may be mediated in part by FAK-associated Src-family PTK activity. Here we show that echistatin treatment of fibronectin-adherent B16-BL6 cells causes a reduction of pp125 FAK ±pp60 src association. Thus, our data suggest that echistatin, by causing the reduction of autophosphorylation activity of pp125 FAK , determines a decreased ability of pp125 FAK to bind and activate Src kinases, thereby reducing paxillin tyrosine phosphorylation.
The role of tyrosine phosphorylation of paxillin in integrindirected signaling is still undetermined. Paxillin forms complexes with other cytoskeletal proteins including vinculin [25] and perhaps talin [40] , in addition to forming complexes with the three PTKs pp125 FAK [23, 40] , pp60 src [31] and Csk [41] , the negative regulator of pp60 src , and with the adapter protein p47 gag±Crk [42] . Therefore, paxillin may serve as an adapter protein itself, a protein that tethers other proteins to a multicomponent complex. Tyrosine phosphorylation of paxillin may regulate protein±protein interactions. It has been suggested that it might also regulate the activation of GTP-binding proteins in a very specific location within the cell [43] . Once active the GTP-binding proteins could transmit a signal to the nucleus and/or a signal inducing structural changes within the cytoskeleton. Thus, echistatin induced reduction of paxillin phosphorylation may represent the event downstream pp125 FAK dephosphorylation by which the disintegrin causes the disassembly of actin cytoskeleton and of focal adhesions.
It is known that many PTKs, including pp125 FAK , and their substrates, such as talin, paxillin and tensin, accumulate at focal adhesions organized by b 1 -containing integrins [44] . These structures seem to represent the privileged site of action of echistatin [13, 36] . Some evidence indicates that tyrosine phosphorylation is involved in the regulation of focal adhesion and stress fiber formation [16, 19, 44] , although the microinjection of a dominant-negative pp125 FAK protein suggested that tyrosine phosphorylation may not be critically involved in the assembly of focal adhesions [26] . Immunofluorescence analysis demonstrates that pp125 FAK and paxillin colocalize in focal adhesions of fibronectin-adherent B16-BL6 cells. However, only a small amount of these proteins is apparently concentrated in these structures, while the largest fraction is in the cytoplasm, in the perinuclear region. The preferential localization of tyrosine phosphorylated paxillin to focal adhesions may represent a general mechanism to compartmentalize focal adhesion components from large nonphosphorylated cytosolic pools [45] . Cell exposure to echistatin inhibits paxillin phosphorylation and causes a dramatic disassembly of focal adhesions, with the simultaneous disappearance of both pp125 FAK and paxillin. The organization and function of focal adhesions is also regulated by protein tyrosine phosphatases (PTPases) [46] . Inhibitors of PTPases prevented most of decrease in protein phosphorylation brought about by cell treatment with trypsin, thus suggesting that PTPases are activated when cell-substratum adhesion is disrupted by trypsin in chicken embryo fibroblasts [47] . However, we previously demonstrated that echistatin acts by inhibiting PTKase activity rather than activating PTPases [13] . Three cellular and one bacterial PTPases have been recently implicated as potential regulators of tyrosine phosphorylation of focal adhesion proteins [46, 48] . PTPase activity was found to specifically associate with pp125 FAK , both in vitro and in vivo: however, this interaction appeared to be indirect and was in part mediated by paxillin [49] . Thus, the finding that paxillin associates with both a PTK and a PTPase suggests a novel model for the regulation of tyrosine phosphorylation by the assembly of complexes containing both enzymes. Paxillin could play a role in coordinating the level of tyrosine phosphorylation of focal adhesion-associated proteins by recruiting PTP and/or pp125 FAK to their substrates. It has been shown that paxillin is directly associated with pp125
FAK , yet their tyrosine phosphorylation does not seem to be necessary for this association [23, 24] . pp125 FAK and paxillin appear to be associated also in the B16-BL6 melanoma cells system either in suspension or after cell adhesion to immobilized fibronectin. However, the amount of paxillin bound to pp125 FAK increases by prolonging the time of cell adhesion. Echistatin treatment of fibronectin-adherent B16-BL6 cells causes a time-dependent decrease of the extent of pp125 FAKpaxillin binding. The disassembly of focal adhesions induced by echistatin involves the simultaneous disappearance of pp125 FAK and paxillin; however, only a small amount of the two proteins remains bound in cells in suspension.
The question regarding the role of the interaction between paxillin and pp125 FAK remains unclear. The carboxy terminus of pp125 FAK supports both paxillin binding and focal adhesion localization. pp125
FAK has been involved in the recruitment of paxillin to focal adhesions [23] but it has also been suggested that pp125
FAK does not target, but is targeted by paxillin to focal adhesions [24] . Further evidence demonstrated that paxillin localizes to focal adhesions independent of interactions with either vinculin and/or pp125 FAK [44] . Even though pp125 FAKpaxillin binding is not necessary or sufficient for focal adhesion localization, it is likely to be necessary for stabilization and maintenance of this subcellular distribution. Further, this interaction may modulate the capacity of these cytoskeletal proteins to interact with many other constituents of the focal adhesion [22] , structurally or enzymatically, thereby modulating the assembly and disassembly of these structures and other signaling pathways associated with integrin functions [50] .
The importance of pp125 FAK in mediating cellular events that govern cell motility has been explored [26, 51] . It has been ascertained that pp125 FAK controls cell spreading, the rate of focal adhesion formation, and cell migration [26, 52, 53] . The forced overexpression of pp125 FAK in CHO cells results in an increase in cell migration [51] . Furthermore, the increased expression of pp125 FAK noted in melanoma cell lines correlates with increased cell motility [54] and the elevated pp125 FAK expression observed in colonic and breast tumors appears to be restricted to invasive as opposed to noninvasive tumors [55, 56] . Thus, pp125 FAK seems to regulate the motility of both normal and malignant cells. Moreover, the recruitment of pp60 src and paxillin by pp125 FAK and the tyrosine phosphorylation of paxillin appear to be limiting events in cell spreading [57] . Disintegrins as well as synthetic RGD-peptides have been shown to inhibit experimental metastasis in vivo [6±10]. The mechanism by which they act still requires further elucidation. However, on the basis of our results we propose that disintegrins exert their antimetastatic activity through the modulation of pp125 FAK autophosphorylation and kinase activity which in turn decrease tyrosine phosphorylation of paxillin and focal adhesion organization, thereby affecting cell adhesion and motility.
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